Allianz Asset Management GmbH Sells 97,505 Shares of athenahealth, Inc. (ATHN)

Allianz Asset Management GmbH lowered its stake in shares of athenahealth, Inc. (NASDAQ:ATHN) by 22.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 332,760 shares of the health services provider’s stock after selling 97,505 shares during the period. Allianz Asset Management GmbH owned 0.83% of athenahealth worth $41,382,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Turner Investments LLC bought a new position in shares of athenahealth in the second quarter worth $105,000. Bessemer Group Inc. increased its holdings in shares of athenahealth by 13.7% in the second quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock worth $132,000 after purchasing an additional 113 shares during the period. The Manufacturers Life Insurance Company increased its holdings in shares of athenahealth by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock worth $166,000 after purchasing an additional 84 shares during the period. BNP Paribas Arbitrage SA increased its holdings in shares of athenahealth by 123.8% in the second quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock worth $189,000 after purchasing an additional 744 shares during the period. Finally, ProShare Advisors LLC bought a new position in shares of athenahealth in the second quarter worth $205,000.

In other news, CEO Jonathan Bush sold 4,000 shares of the firm’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $124.17, for a total transaction of $496,680.00. Following the transaction, the chief executive officer now directly owns 319,807 shares of the company’s stock, valued at $39,710,435.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Jonathan D. Porter sold 300 shares of the firm’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $130.38, for a total value of $39,114.00. The disclosure for this sale can be found here. Insiders have sold 9,283 shares of company stock worth $1,175,908 over the last ninety days. Insiders own 3.20% of the company’s stock.

Several research analysts have recently weighed in on the stock. BidaskClub raised shares of athenahealth from a “strong sell” rating to a “sell” rating in a report on Saturday, December 2nd. Cantor Fitzgerald reissued a “hold” rating and issued a $120.00 target price on shares of athenahealth in a research note on Friday, October 27th. SunTrust Banks reissued a “buy” rating and issued a $156.00 target price on shares of athenahealth in a research note on Wednesday, October 25th. Leerink Swann reduced their target price on athenahealth from $155.00 to $125.00 and set a “market perform” rating on the stock in a research note on Monday, October 23rd. Finally, Wells Fargo & Company reduced their target price on athenahealth from $190.00 to $155.00 and set an “outperform” rating on the stock in a research note on Monday, October 23rd. Two analysts have rated the stock with a sell rating, fourteen have issued a hold rating and eleven have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $143.22.

athenahealth, Inc. (NASDAQ ATHN) opened at $135.55 on Friday. athenahealth, Inc. has a 12 month low of $90.11 and a 12 month high of $158.66. The stock has a market capitalization of $5,356.37, a PE ratio of 113.43, a PEG ratio of 5.02 and a beta of 1.57. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.67 and a current ratio of 1.67.

athenahealth (NASDAQ:ATHN) last announced its quarterly earnings data on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.06. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The firm had revenue of $304.60 million for the quarter, compared to analysts’ expectations of $310.52 million. During the same period last year, the firm earned $0.60 earnings per share. The company’s revenue for the quarter was up 10.1% compared to the same quarter last year. sell-side analysts anticipate that athenahealth, Inc. will post 1.2 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.chaffeybreeze.com/2017/12/08/allianz-asset-management-gmbh-sells-97505-shares-of-athenahealth-inc-athn.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply